Maria E. Figueroa

Two-step upflow anaerobic sludge bed system for sewage treatment under subtropical conditions with posttreatment in waste stabilization ponds.

Comparative isoschizomer profiling of cytosine methylation: the HELP assay.

Smad1 and Smad5 differentially regulate embryonic hematopoiesis.

CG dinucleotide clustering is a species-specific property of the genome.

An integrative genomic and epigenomic approach for the study of transcriptional regulation.

Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines.

Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features.

Genome-wide determination of DNA methylation by Hpa II tiny fragment enrichment by ligation-mediated PCR (HELP) for the study of acute leukemias.

High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers.

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.

DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.

HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay for DNA methylation profiling of primary normal and malignant B lymphocytes.

DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.

Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.

BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation.

IDH mutation impairs histone demethylation and results in a block to cell differentiation.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.

Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.

IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics.

CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.

H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia.

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis.

methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles.

C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.

Interpreting new molecular genetics in myelodysplastic syndromes.

Notch activation inhibits AML growth and survival: a potential therapeutic approach.

Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment.

Understanding and utilizing new molecular genetics in MDS.

Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.

Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.

Epigenetic roles of MLL oncoproteins are dependent on NF-κB.

PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex.

Microsphere-based multiplex analysis of DNA methylation in acute myeloid leukemia.

Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.

Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling.

Epigenetic deregulation in myeloid malignancies.

MethylSig: a whole genome DNA methylation analysis pipeline.

Validation of DNA methylation to predict outcome in acute myeloid leukemia by use of xMELP.

DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.

Plasticity of DNA methylation in a nerve injury model of pain.

Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.